The clinical study of extranodal natural killer cell lymphoma, nasal type

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Gui, Wei ^a   Zhao, Zhiqiang ^a   Shen, Quanliang ^b   Wang, Tong ^b   Yang, Bin ^a   He, Jianxia ^a   Li, Xi ^a   Hou, Shuling ^a   Zhang, Li ^a   Zhang, Qiaohua ^a   Su, Liping ^a  

^a SHANXI TUMOR HOSPITAL   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Characterize; Extranasal NK T lymphoma; Extranodal natural killer cell lymphoma, nasal type; Nasal NK T lymphoma; Prognosis; Treatment

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

ACUTE PANCREATITIS; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HEMOPTYSIS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; LAPAROTOMY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 84555203157     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9756-0     Document Type: Article

References (16)

1. K Oshimi 2007 Progress in understanding and managing natural killer-cell malignancies Br J Haematol 139 532 544 (Pubitemid 350043813)
2. X Liang DK Graham 2008 Natural killer cell neoplasma Cancer 112 1425 1436
3. CS Chim SY Ma WY Au 2004 Primary nasal natural killer cell lymphoma :long-term treatment outcome and relationship with the international prognostic index Blood 103 216 221
4. YL Kwong 2005 Natural killer-cell malignancies: diagnosis and treatment Leukemia 19 2186 2194
5. 56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm Blood 89 4501 4513 (Pubitemid 27260260)
6. YL Choi JH Park JH Namkung 2009 Extranodal NK/T-cell lymphoma with cutaneous involvement:'nasal' vs'.nasal-type' subgroups retrospective study of 18 patients Br J Dermatol 160 333 337
7. + hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature Ann Oncol 15 1097 1108 (Pubitemid 39089788)
8. ST Lim SW Hee R Quek 2007 Comparative analysis of extranodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis E J Haematol 80 55 60 (Pubitemid 350265229)
9. J Lee C Suh YH Park 2006 Extranodal natural killer T-cell lymphoma, nasal type: a prognostic model from a retrospective multicenter Study J Clin Oncol 24 612 618 (Pubitemid 46630424)
10. X Wu P Li J Zhao 2008 A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type J Clin Oncol 20 619 625
11. W Yong W Zheng J Zhu 2009 L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type Ann Haematol 88 647 652
12. PH Shaw SL Cohn ER Morgan 2001 Natural killer cell lymphoma report of two pediatric cases, therapeutic options, and review of the literature Cancer 91 642 646 (Pubitemid 32175125)
13. R Liang 2009 Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type Br J Haematol 147 13 21
14. C Massone A Chott D Metze 2004 Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin a morphologic, immunophenotypic, and molecular study of 50 patients Am J Surg Pathol 28 719 735 (Pubitemid 38685886)
15. R Suzuki J Suzumiya K Oshimi 2009 Differences between nasal and extranasal NK/T-cell lymphoma Blood 113 6260 6261
16. W Au DD Weisenburger T Intragumtornchai 2009 Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell lymphoma project Blood 113 3931 3937